[e-drug] Drug Therap Committees - Training of trainers

E-DRUG: Drug Therap Committees - Training of trainers
-----------------------------------------------------

Announcing the Regional Training Course on Drug & Therapeutics
Committees and Training of Trainers, August 29 to September 11, 2004,
Kampala, Uganda

The Department of Pharmacology and Therapeutics and the Department of
Pharmacy at the Faculty of Medicine, Makerere University, Uganda will
host a Regional Training Course on Drug and Therapeutics Committees and
Training of Trainers from August 29 to September 11, 2004 in Kampala,
Uganda. The course is organized by the Makerere University Faculty of
Medicine, Uganda Ministry of Health, and Rational Pharmaceutical
Management Plus (RPM Plus) Program of Management Sciences for Health
(MSH) in collaboration with the WHO Department of Essential Drugs and
Medicines Policy and INRUD-Uganda. The course is supported by the U.S.
Agency for International Development.

Who Should Attend?
-----------------

The course is designed for physicians, pharmacists, and health officials
in hospitals, ministries of health, universities or private
organizations. Those interested in improving formulary management and
promoting rational use of drugs through drug and therapeutics committees
(DTCs) and are in a position to provide training and technical
assistance to other DTCs, are invited to apply. Candidates with some
experience with drug and therapeutics committees, who wish to expand
their knowledge of drug management and train others back in their
country/region, are preferred.

Course Focus
------------

The training course will focus on the role of the drug and therapeutic
committee and the practical approaches available in promoting rational
use of drugs. Key features will include - * Formulary management *
Standard treatment guidelines * Essential drug list * Indicators of drug
use * Interventions to change inappropriate drug use * Practical aspects
of running a DTC

The last three days of the course will focus on training of the trainers
(TOT) aspects and is designed to help the participants to better prepare
themselves to provide DTC-related training to others in their respective
countries and regions. Key features of the TOT component will include -
* Adult learning * Role of teacher * Communication skills * Teaching and
learning methods * DTC-related presentation and facilitation skills

Design and Methods
------------------

The highly participatory course will be conducted in English and will
consist of -
* Presentations * Discussions * Small group activities * Field visits

The DTC training will be based on materials developed by MSH, in
collaboration with WHO and will allow for the exchange of experiences
and ideas among participants, adding depth to the learning process. This
will expose participants to a wide range of international experiences
and materials. The TOT training will be based on the materials recently
developed by RPM Plus/MSH. The course materials will emphasize -

* Identifying and understanding drug use problems
* Formulary management and standard treatment guidelines
* Assessing drug efficacy, safety, quality
* Cost evaluation of formulary drugs
* Drug utilization review
* Strategies to improve drug use
* Structure and function of a DTC
* Infection control
* Monitoring and evaluating a DTC
* Local hospital field study
* Adult learning and teaching learning methods
* Communication, presentation and facilitation skills

Faculty
-------

A team of experts from RPM Plus/MSH, WHO and Makerere University School
of Medicine will serve as trainers. They include -

Dr. Mohan P. Joshi is Project Manager for Antimicrobial Resistance (AMR)
at the Rational Pharmaceutical Management Plus (RPM Plus) Program of the
MSH Center for Pharmaceutical Management. He has his first degree in
medicine and post-graduate degrees in clinical pharmacology and
pharmacology. Dr. Joshi has more than 20 years of professional
experience and was working as Assistant Dean, Professor & Head of
Clinical Pharmacology, and Director of Drug Information Center at the
Tribhuvan University Institute of Medicine in Nepal prior to joining the
MSH. Dr. Joshi has served as a member of the International Health Expert
Advisory Panel of the U.S. Pharmacopeia. He has coordinated and
facilitated many training courses on rational drug use.

Dr. Patricia Paredes is a Regional Project Manager for RPM Plus/MSH. She
has more than 18 years experience working on community health programs
around the world. Before joining MSH, she worked with the Institute of
Nutritional Research in Peru, at the Ministry of Health, the Center for
Communications Programs at Johns Hopkins University, and the Institute
of Reproductive Health at Georgetown University. At MSH, she provides
technical assistance to programs in Latin America and the Caribbean by:
collaborating on Regional Initiatives addressing Malaria, Tuberculosis,
Antimicrobial Resistance, and Health Sector Reform; conducting
pharmaceutical sector analysis; supporting initiatives to improve the
use of medicines; and conducting trainings in the rational use and
management of drugs.

Dr. Kathleen Holloway is a medical officer with EDM/WHO in Geneva. Her
present responsibility is the promotion of the rational use of drugs at
both global and country levels, and she is actively involved in training
programs, research, and capacity building in this area. Her professional
experience includes 10 years as a clinician in the UK National Health
Service, 10 years working in Asia in both clinical medicine and public
health, and 5 years working in international health. She spent 1991-1998
in Nepal managing an essential drugs program and she conducted research
into the effects of user fees on rational drug use. Dr. Holloway is
particularly interested in financial mechanisms to promote more rational
use of drugs and in containing antimicrobial resistance.

Dr. Jasper Ogwal-Okeng is an Associate Professor and Head of
Pharmacology and Therapeutics, Makerere University. He is very active in
research and other activities aimed at improving the use of medicines in
Uganda. Dr Ogwal-Okeng has facilitated several seminars and workshops on
improving the use of medicines for physicians, nurses and other health
cadres in Uganda. He was a major player in organizing and running the
'Promoting Rational Drug Use' course in Kampala in 1996. He was also
invited to facilitate at the PBL Pharmacotherapy Course in Groningen,
Holland in 1995.

Prof. Willy Anokobonggo is a clinical Pharmacologist by specialization.
He worked with the Uganda Ministry of Health as a medical doctor before
moving to Makerere University, Faculty of Medicine, where he currently
serves as Professor of Pharmacology and Therapeutics. He was an
Associate Dean in Makerere Medical School between 1990-1994 and Head of
the Department of Pharmacology and Therapeutics between 1981-1990.
Currently, he is the coordinator of INRUD-Uganda, conducting and
supervising research activities aimed at improving the use of medicines.
He has participated in organizing several regional training courses and
symposia in medicines use.

Fees and Application
--------------------

The course fee is US $ 2200. This fee covers tuition, training course
materials, shared accommodation, breakfast, and lunch. Those who require
single room accommodation must pay extra charges (information available
on request).

Participants will be provided $20/day to cover expenses for regular
dinners not provided by the organizers. Participants should plan to
bring sufficient money for incidental expenses like laundry, postage,
phone calls, etc. Travel and health insurance are the responsibility of
the sponsoring organization.

The course fee for local participants not requiring accommodation is US
$1500. This fee covers tuition, training course materials, and lunch. It
does not cover transport to and from the course, breakfast, dinner or
hotel accommodations.

Participants should arrive in Kampala on August 28 or latest by 1.00pm
on August 29, 2004. The organizing committee will be responsible for
hotel accommodation till 10.00am of September 12, 2004. Those who want
to stay longer will themselves have to pay for accommodation from then
on.

Places for 35 participants (national and international) will be
available. Since it is a regional course, preference will be given to
participants from Africa region. Selection will be based on previous
experience, interest in promoting rational use of drugs through the DTC,
and ability to implement such programs in their own environment.

Bank details are as follows:
---------------------------

Bankdrafts should be made payable to INRUD-Uganda in US dollars.

Payment by direct transfer is preferred. Wire transfers can be sent to:

Standard Chartered Bank Uganda Limited
Speke Road Branch
P.O. Box 7111
Kampala, Uganda

SWIFT code: SCBLUGKA

Name on the account: INRUD-Uganda.
Account number: 870 821 181 2500

Account holder's address:

INRUD-Uganda
Department of Pharmacology
Makerere University
PO Box 7072
Kampala, Uganda

The correspondent bank for US dollar transfers is:

Standard Charter Bank
One Madison Avenue
New York, NY 10010-3603
U.S.A.
(212) 667-0700

SWIFT code: SCBLUS33
ABA code: 026002561

Deadline for Application
------------------------

Applications and fees are due no later than July 25, 2004. Due to a
limit of 35 participants, applicants are encouraged to apply early.

For a copy of the application and this course flyer, please visit
http://erc.msh.org/dtc

For further information, please send an e-mail to Dr. Paul Waako at
pwaako@med.mak.ac.ug
with copies to: Dr. Jasper Ogwal-Okeng at jogwal@utlonline.co.ug, Dr.
Mohan P. Joshi at mjoshi@msh.org, and Sarah Paige at spaige@msh.org

-------------------------------------------------
Mohan P. Joshi, MBBS, MSc, MD
Project Manager for Antimicrobial Resistance
Rational Pharmaceutical Management Plus Program
Center for Pharmaceutical Management
Management Sciences for Health
4301 North Fairfax Drive, Suite 400
Arlington, VA 22203-1627, USA
Tel Main: 703-524-6575
Tel Direct: 703-248-1635
Fax: 703-524-7898
Email: mjoshi@msh.org
URL: http://www.msh.org

--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug